Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

pathbioanalytics.com

Founded Year

2014

Stage

Seed | Alive

Total Raised

$100K

Last Raised

$100K | 2 yrs ago

About Path BioAnalytics

Path BioAnalytics provides in vitro screening in SARS-CoV-2-infected human respiratory organoids.

Path BioAnalytics Headquarters Location

Singapore

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Path BioAnalytics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Path BioAnalytics is included in 4 Expert Collections, including Medical Devices.

M

Medical Devices

8,487 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health Monitoring & Diagnostics

2,412 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

R

Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

H

Health IT

7,901 items

Path BioAnalytics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Path BioAnalytics Rank

  • When was Path BioAnalytics founded?

    Path BioAnalytics was founded in 2014.

  • What is Path BioAnalytics's latest funding round?

    Path BioAnalytics's latest funding round is Seed.

  • How much did Path BioAnalytics raise?

    Path BioAnalytics raised a total of $100K.

  • Who are the investors of Path BioAnalytics?

    Investors of Path BioAnalytics include Antler.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.